A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases

[1] Adam R(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657

[2] Delvart V(2011)Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol Cancer 117 343-352

[3] Pascal G(2013)Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial Lancet Oncol 14 29-37

[4] Albert M(2010)FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases Anticancer Res 30 1015-1020

[5] Kiefer MV(2011)Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases J Cancer Res Clin Oncol 137 865-873

[6] Sun W(2009)Selective internal radiation therapy with SIRspheres for the treatment of unresectable colorectal hepatic metastases Cardiovasc Intervent Radiol 32 1179-1186

[7] Bennouna J(2010)Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Br J Cancer 103 324-331

[8] Sastre J(2007)Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the gruppo oncologico nord ovest J Clin Oncol 25 1670-1676

[9] Arnold D(2012)Intra-arterial infusion of irinotecan-loaded drugeluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 1387-1395

[10] Beppu T(2010)Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 38-47

[1] Adam R(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657

[2] Delvart V(2011)Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol Cancer 117 343-352

[3] Pascal G(2013)Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial Lancet Oncol 14 29-37

[4] Albert M(2010)FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases Anticancer Res 30 1015-1020

[5] Kiefer MV(2011)Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases J Cancer Res Clin Oncol 137 865-873

[6] Sun W(2009)Selective internal radiation therapy with SIRspheres for the treatment of unresectable colorectal hepatic metastases Cardiovasc Intervent Radiol 32 1179-1186

[7] Bennouna J(2010)Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Br J Cancer 103 324-331

[8] Sastre J(2007)Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the gruppo oncologico nord ovest J Clin Oncol 25 1670-1676

[9] Arnold D(2012)Intra-arterial infusion of irinotecan-loaded drugeluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 1387-1395

[10] Beppu T(2010)Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 38-47